Medical Innovation Exchange

ESMO: AstraZeneca spinout Dizal planning phase 3 NSCLC study in US before year’s end

https://www.fiercebiotech.com/biotech/esmo-dizal-planning-launch-phase-3-nsclc-study-us-years-end

Leave a Comment

Your email address will not be published.

Leave the field below empty!